Epigenetic Mechanisms of Promigratory Chemokine CXCL14 Regulation in Human Prostate Cancer Cells

被引:37
|
作者
Song, Eun Young [3 ]
Shurin, Michael R. [1 ,2 ]
Tourkova, Irina L. [1 ]
Gutkin, Dmitriy W. [4 ]
Shurin, Galina V. [1 ]
机构
[1] Univ Pittsburgh, Med Ctr, Dept Pathol, Pittsburgh, PA 15261 USA
[2] Univ Pittsburgh, Med Ctr, Dept Immunol, Pittsburgh, PA 15261 USA
[3] Seoul Natl Univ, Coll Med, Seoul, South Korea
[4] VA Healthcare Syst, Pittsburgh, PA USA
关键词
ABERRANT PROMOTER METHYLATION; TUMOR-SUPPRESSOR GENE; DENDRITIC CELLS; DNA HYPERMETHYLATION; HUMAN BREAST; IN-VITRO; EXPRESSION; BRAK; INFILTRATION; REACTIVATION;
D O I
10.1158/0008-5472.CAN-10-0427
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Chemokines play the key role in initiating immune responses by regulating the attraction and homing of immune cells to the lymphoid and nonlymphoid tissues. CXCL14 is a chemokine that in tumors may act as chemoattractant for monocytes and dendritic cells (DC), which may modulate antitumor immune responses in certain cancers. In this study, we investigated the mechanisms of loss of CXCL14 in prostate cancer cells. Cell treatment with the demethylating agent 5-aza-2-deoxycytidine resulted in the recovery of CXCL14 mRNA and protein expression. Hypermethylated CpG island sequences encompassing the CXCL14 gene promoter were identified. The restoration of CXCL14 by 5-aza-2-deoxycytidine treatment had functional impact, based on the DC chemoattractant activity of conditioned medium from drug-treated cells. Conversely, CXCL14 removal from conditioned media by affinity chromatography abolished its chemotactic properties, confirming that functionally active CXCL14 was generated in prostate cancer cells by relieving its transcriptional silencing with 5-aza-2-deoxycytidine. Our findings offer the first direct evidence for epigenetic regulation of chemokine expression in tumor cells. Cancer Res; 70(11); 4394-401. (C) 2010 AACR.
引用
收藏
页码:4394 / 4401
页数:8
相关论文
共 50 条
  • [41] The Expression of the Chemokine CXCL14 Correlates with Several Aggressive Aspects of Glioblastoma and Promotes Key Properties of Glioblastoma Cells
    Fazi, Barbara
    Proserpio, Carla
    Galardi, Silvia
    Annesi, Francesca
    Cola, Mattia
    Mangiola, Annunziato
    Michienzi, Alessandro
    Ciafre, Silvia Anna
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2019, 20 (10)
  • [42] Chemokine CXCL14/BRAK transgenic mice suppress growth of carcinoma cell xenografts
    Izukuri, Kazuhito
    Suzuki, Kenji
    Yajima, Nobuyuki
    Ozawa, Shigeyuki
    Ito, Shin
    Kubota, Eiro
    Hata, Ryu-Ichiro
    TRANSGENIC RESEARCH, 2010, 19 (06) : 1109 - 1117
  • [43] Epithelial chemokine CXCL14 synergizes with CXCL12 via allosteric modulation of CXCR4
    Collins, Paul J.
    McCully, Michelle L.
    Martinez-Munoz, Laura
    Santiago, Cesar
    Wheeldon, James
    Caucheteux, Stephan
    Thelen, Sylvia
    Cecchinato, Valentina
    Laufer, Julia M.
    Purvanov, Vladimir
    Monneau, Yoan R.
    Lortat-Jacob, Hugues
    Legler, Daniel F.
    Uguccioni, Mariagrazia
    Thelen, Marcus
    Piguet, Vincent
    Mellado, Mario
    Moser, Bernhard
    FASEB JOURNAL, 2017, 31 (07): : 3084 - 3097
  • [44] Inhibition of insulin secretion by the chemokine Cxcl14 via a cAMP-independent pathway
    Atanes, P.
    Hawkes, R. G.
    Ruz-Maldonado, I.
    Olaniru, O.
    Liu, B.
    Amisten, S.
    Persaud, S. J.
    DIABETOLOGIA, 2018, 61 : S204 - S205
  • [45] Improving our understanding of CXCL14, one of the few remaining unknowns in chemokine biology
    Collins, P. J.
    Liao, C-T
    Price, D.
    Moser, B.
    IMMUNOLOGY, 2014, 143 : 85 - 85
  • [46] CXCL5 and CXCL14, but not CXCL16 as potential biomarkers of colorectal cancer
    Zajkowska, Monika
    Dulewicz, Maciej
    Kulczynska-Przybik, Agnieszka
    Safiejko, Kamil
    Juchimiuk, Marcin
    Konopko, Marzena
    Kozlowski, Leszek
    Mroczko, Barbara
    SCIENTIFIC REPORTS, 2023, 13 (01)
  • [47] CXCL5 and CXCL14, but not CXCL16 as potential biomarkers of colorectal cancer
    Monika Zajkowska
    Maciej Dulewicz
    Agnieszka Kulczyńska-Przybik
    Kamil Safiejko
    Marcin Juchimiuk
    Marzena Konopko
    Leszek Kozłowski
    Barbara Mroczko
    Scientific Reports, 13
  • [48] Chemokine CXCL14/BRAK transgenic mice suppress growth of carcinoma cell xenografts
    Kazuhito Izukuri
    Kenji Suzuki
    Nobuyuki Yajima
    Shigeyuki Ozawa
    Shin Ito
    Eiro Kubota
    Ryu-Ichiro Hata
    Transgenic Research, 2010, 19 : 1109 - 1117
  • [49] Chemokine CXCL14 is associated with prognosis in patients with colorectal carcinoma after curative resection
    Zeng, Jun
    Yang, Xudan
    Cheng, Lin
    Liu, Rui
    Lei, Yunlong
    Dong, Dandan
    Li, Fanghua
    Lau, Quek Choon
    Deng, Longfei
    Nice, Edouard C.
    Xie, Ke
    Huang, Canhua
    JOURNAL OF TRANSLATIONAL MEDICINE, 2013, 11
  • [50] Expression of the chemokine CXCL14 is a predictive biomarker for cetuximab-dependent tumor suppression
    Hata, Ryuichiro
    Kato, Iyoko
    Kurata, Shunichi
    CANCER SCIENCE, 2024, 115 : 1283 - 1283